PTC Therapeutics Inc (NASDAQ: PTCT) Could Be Viewed Differently By Investors Because Of These Numbers

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Recently, Yahoo Finance discussed the stock, revealing that PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 42nd Annual J.P. Morgan Healthcare Conference.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $28.10 and fluctuated between $28.79 as its day high and $27.16 as its day low. The current market capitalization of PTC Therapeutics Inc is $2.12B. A total of 0.89 million shares were traded on the day, compared to an average of 1.28M shares.

Insider Activity

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, PTCT has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 23 BUYs and 54 SELLs from insiders. Insiders purchased 224,728 shares during that period but sold 204,557.

In the most recent transaction, Klein Matthew B. sold 5,443 shares of PTCT for 29.01 per share on Jan 09. After the transaction, the CHIEF EXECUTIVE OFFICER now owns 160,475 company shares. In a previous transaction on Jan 09, Pauwels Eric sold 2,065 shares at 29.01 per share. PTCT shares that CHIEF BUSINESS OFFICER owns now total 44,547.

Among the insiders who sold shares, Boulding Mark Elliott disposed of 1,938 shares on Jan 09 at a per-share price of $29.01. This resulted in the EXEC. VP AND CLO holding 71,983 shares of PTCT after the transaction. In another insider transaction, Utter Christine Marie sold 1,653 shares at $29.01 per share on Jan 09. Company shares held by the SVP, FINANCE & CAO now total 35,846.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for PTCT in the last 3 months, the mean price target is $29.15 with high estimates of $51.00 and low estimates of $17.00. In terms of 52-week highs and lows, PTCT has a high of $59.84 and a low of $17.53.

As of this writing, PTCT has an earnings estimate of $0.5 per share for the current quarter. EPS was calculated based on a consensus of 14 estimates, with a high estimate of $1.47 per share and a lower estimate of -$1.1. The company reported an EPS of -$2.66 in the last quarter, which was -114.50% lower than expectations of -$1.24.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. PTCT’s latest balance sheet shows that the firm has $773.38M in Cash & Short Term Investments as of fiscal 2021. There were $535.38M in debt and $509.35M in liabilities at the time. Its Book Value Per Share was -$8.89, while its Total Shareholder’s Equity was $1.44M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PTCT is Buy with a score of 3.13.

Most Popular

Related Posts